Orion Portfolio Solutions, LLC Mirati Therapeutics, Inc. Transaction History

Orion Portfolio Solutions, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$27.8 - $45.35 $193,043 - $314,910	6,944 Added 31.12%	29,261 $1.27 Million
Q2 2023 Aug 14, 2023	SELL	$36.13 - $49.49 $26,338 - $36,078	-729 Reduced 3.16%	22,317 $806,000
Q1 2023 Aug 30, 2023	BUY	$36.54 - $54.26 $26,637 - $39,555	729 Added 3.27%	23,046 $856,000
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $842,100 - $1.25 Million	23,046 New	23,046 $856,000
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $69 - $116	-1 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $70 - $128	1 New	1 $0

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.